Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Photocure ASA (PHS) vs. Competitors

1 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:PHSPhotocure ASAEUR 3.86EUR 100.87M22.62-25.15%―Unlock the DE:PHS analyst price target with TipRanks PremiumDE:PHSUnlock the DE:PHS top-analyst price target with TipRanks Premium
PHCUFPhotocure ASA$4.30$110.64M22.62-26.75%―Unlock the PHCUF analyst price target with TipRanks PremiumDE:PHS vs PHCUFUnlock the PHCUF top-analyst price target with TipRanks Premium
EGRXEagle Pharmaceuticals$0.65$8.47M0.23-50.00%―Unlock the EGRX analyst price target with TipRanks PremiumDE:PHS vs EGRXUnlock the EGRX top-analyst price target with TipRanks Premium
OMEROmeros$14.55$1.08B9.1571.18%Moderate BuyUnlock the OMER analyst price target with TipRanks PremiumDE:PHS vs OMERUnlock the OMER top-analyst price target with TipRanks Premium
TNXPTonix Pharma$2.82$57.13M-0.22-82.71%Strong BuyUnlock the TNXP analyst price target with TipRanks PremiumDE:PHS vs TNXPUnlock the TNXP top-analyst price target with TipRanks Premium
ONCYOncolytics Biotech$0.44$59.94M-1.55-57.28%Moderate BuyUnlock the ONCY analyst price target with TipRanks PremiumDE:PHS vs ONCYUnlock the ONCY top-analyst price target with TipRanks Premium
PFEPfizer$28.06$162.27B39.7010.26%HoldUnlock the PFE analyst price target with TipRanks PremiumDE:PHS vs PFEUnlock the PFE top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%500%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:PHSPhotocure ASA3.85-1.12-22.51%
PHCUFPhotocure ASA4.30-1.48-25.61%
EGRXEagle Pharmaceuticals0.65-0.13-16.67%
OMEROmeros14.556.3377.01%
TNXPTonix Pharma2.82-13.90-83.13%
ONCYOncolytics Biotech0.44-0.60-57.69%
PFEPfizer28.064.7420.34%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts